Company / Gross Margin
Amneal Pharmaceuticals, Inc. Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
36.9%
FY2025
5-year range
21.7% / 36.9%
FY2021-FY2025
Trend
+1.0%
vs FY2024
Sector context
#22 of 28
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s gross margin of 36.9% is lower than 79% of companies in the Health Care sector (FY2025). Gross Margin has fluctuated over the past 10 years, ranging from 21.7% in FY2021 to 58.7% in FY2018.
Based on SEC 10-K filings.
36.9% in FY2025 with a 5-year CAGR of -6.2%.
Remained stable around 36.9% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +1.4pp
- 5-Year Change
- -6.2pp
- 10-Year Change
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 28This company 36.9% Sector average 60.3%
▼
-38.8% below sector average
Key checks
Key Insights
- In FY2025, gross margin increased 1.0% year-over-year.
- Currently 23.4pp below the Health Care sector average.
- Peak gross margin was recorded in FY2018.
- Lowest gross margin in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 36.9% | +1.0% |
| FY2024 | 36.5% | -0.6% |
| FY2023 | 36.7% | +3.6% |
| FY2022 | 35.5% | +63.5% |
| FY2021 | 21.7% | -49.6% |
| FY2020 | 43.1% | -15.4% |
| FY2019 | 50.9% | -13.3% |
| FY2018 | 58.7% | +15.3% |
| FY2017 | 50.9% | -13.3% |
| FY2016 | 58.7% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026